Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Ovid Therapeutics (OVID) over the last 4 years, with Q3 2025 value amounting to $300000.0.

  • Ovid Therapeutics' Amortizatization of Intangibles rose 830.32% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 817.84%. This contributed to the annual value of $1.1 million for FY2024, which is 671.21% up from last year.
  • According to the latest figures from Q3 2025, Ovid Therapeutics' Amortizatization of Intangibles is $300000.0, which was up 830.32% from $294000.0 recorded in Q2 2025.
  • In the past 5 years, Ovid Therapeutics' Amortizatization of Intangibles registered a high of $354185.0 during Q2 2022, and its lowest value of $253000.0 during Q1 2023.
  • In the last 4 years, Ovid Therapeutics' Amortizatization of Intangibles had a median value of $269000.0 in 2024 and averaged $276864.3.
  • Per our database at Business Quant, Ovid Therapeutics' Amortizatization of Intangibles tumbled by 2715.67% in 2023 and then skyrocketed by 830.32% in 2025.
  • Ovid Therapeutics' Amortizatization of Intangibles (Quarter) stood at $254970.0 in 2022, then increased by 2.36% to $261000.0 in 2023, then grew by 8.05% to $282000.0 in 2024, then increased by 6.38% to $300000.0 in 2025.
  • Its Amortizatization of Intangibles was $300000.0 in Q3 2025, compared to $294000.0 in Q2 2025 and $288000.0 in Q1 2025.